Lumenis Ltd, an energy-based medical device company, has launched its new Digital Duet, claimed to be the first digital SLT-YAG system on the market, it was reported on Thursday.
The company said that Digital Duet takes gold-standard laser glaucoma treatment and posterior capsulotomy to the next level with the launch of advanced digital and connectivity capabilities, completely redefining the platform. The new Digital Duet streamlines workflow in the ophthalmology practice. Doctors can seamlessly generate reports and save data, images and video to the practice network and the electronic medical record, with no need for additional documentation or laser logs.
Dr Nathan M Radcliffe of the New York Eye and Ear Infirmary, New York City, said, 'The Digital Duet's digital imaging capabilities are allowing me to document pathologies. Also, I can now share images with my patients to help them understand their conditions and feel comfortable with therapy. It's exciting to get these totally new capabilities in a system with the enhanced energy control, visualisation and precision I need to achieve the outcomes I want for patients with glaucoma.'
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study
BD receives CE Mark for Revello vascular covered stent
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed